IDYA — Ideaya Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual balance sheet for Ideaya Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	284	247	365	525	676
Net Total Accounts Receivable
Net Total Receivables	1.88	1.1	0.211	0.018	0.003
Prepaid Expenses
Total Current Assets	289	251	370	533	690
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	9.48	8.66	8.99	8.41	27.7
Long Term Investments
Other Long Term Assets
Total Assets	298	381	388	649	1,124
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	38.6	45.2	31.7	27.1	46.1
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	100	79.8	38.5	28.2	64.9
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	198	302	349	621	1,059
Total Liabilities & Shareholders' Equity	298	381	388	649	1,124
Total Common Shares Outstanding